Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea.

Cunningham R, Dale B, Undy B, Gaunt N.

J Hosp Infect. 2003 Jul;54(3):243-5.

PMID:
12855243
2.
3.

Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.

Yearsley KA, Gilby LJ, Ramadas AV, Kubiak EM, Fone DL, Allison MC.

Aliment Pharmacol Ther. 2006 Aug 15;24(4):613-9.

4.
5.

Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding.

Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN.

Ann Intern Med. 1998 Dec 15;129(12):1012-9.

PMID:
9867755
6.

Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.

Leonard AD, Ho KM, Flexman J.

Intern Med J. 2012 May;42(5):591-4. doi: 10.1111/j.1445-5994.2012.02770.x.

PMID:
22616966
7.

Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.

Aseeri M, Schroeder T, Kramer J, Zackula R.

Am J Gastroenterol. 2008 Sep;103(9):2308-13. doi: 10.1111/j.1572-0241.2008.01975.x. Epub 2008 Aug 12.

PMID:
18702653
8.

Risk factors for Clostridium difficile infection.

Bignardi GE.

J Hosp Infect. 1998 Sep;40(1):1-15.

PMID:
9777516
9.

Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study.

Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN.

Clin Infect Dis. 2006 Nov 15;43(10):1272-6. Epub 2006 Oct 13.

PMID:
17051491
10.

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D.

Arch Intern Med. 2010 May 10;170(9):784-90. doi: 10.1001/archinternmed.2010.89.

PMID:
20458086
11.

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

McFarland LV, Clarridge JE, Beneda HW, Raugi GJ.

Clin Infect Dis. 2007 Nov 1;45(9):1141-51. Epub 2007 Sep 26.

PMID:
17918075
12.

Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.

Stevens V, Dumyati G, Brown J, Wijngaarden E.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1035-42. doi: 10.1002/pds.2198. Epub 2011 Aug 10.

PMID:
21833992
13.

Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.

Vesteinsdottir I, Gudlaugsdottir S, Einarsdottir R, Kalaitzakis E, Sigurdardottir O, Bjornsson ES.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2601-10. Epub 2012 Mar 23.

PMID:
22441775
14.

Clostridium difficile infection and proton pump inhibitors.

Pohl JF.

Curr Opin Pediatr. 2012 Oct;24(5):627-31. doi: 10.1097/MOP.0b013e328355a3e1. Review.

PMID:
22781139
15.

Antibiotic prescribing policy and Clostridium difficile diarrhoea.

O'Connor KA, Kingston M, O'Donovan M, Cryan B, Twomey C, O'Mahony D.

QJM. 2004 Jul;97(7):423-9.

PMID:
15208430
16.

Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.

Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR.

Mayo Clin Proc. 2013 Oct;88(10):1085-90. doi: 10.1016/j.mayocp.2013.07.004. Epub 2013 Sep 5.

PMID:
24012413
17.

Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.

Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ.

Aliment Pharmacol Ther. 2009 Mar 15;29(6):626-34. doi: 10.1111/j.1365-2036.2008.03924.x. Epub 2008 Dec 19.

18.

Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward.

Gifford AH, Kirkland KB.

Eur J Clin Microbiol Infect Dis. 2006 Dec;25(12):751-5.

PMID:
17072575
19.

Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.

Biswal S.

Biomed J. 2014 Jul-Aug;37(4):178-83. doi: 10.4103/2319-4170.128002. Review.

20.

Proton pump inhibitors are an independent risk factor for an increased length of hospital stay in patients with Clostridium difficile infection.

Nachnani JS, Bulchandani D, Allen MJ.

Indian J Gastroenterol. 2008 Jul-Aug;27(4):171-2. No abstract available.

PMID:
18974472

Supplemental Content

Support Center